DTIL
DTIL
NASDAQ · Biotechnology

Precision Biosciences Inc

$5.42
-0.60 (-9.97%)
As of Mar 30, 10:09 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +466.2% upside
Low Target $21.79
Average Target $30.69
High Target $37.55
Current Price $5.42
Current
$5.42
Target
$30.69
$21.79 $30.69 avg $37.55
Scenario Analysis
Bear Case
$21.79
302.0%
Low target
Base Case
$30.69
+466.2%
Avg target
Bull Case
$37.55
+592.8%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$8.82
-38.5% from high
52-Week Low
$3.53
+53.5% from low
Target vs 52W High
$30.69
+248.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%